Figure 2
From: Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays
Correlation of clinico-pathological parameters with immunostaining of MYC, BARK1 and PP1α in prostate tumour and BPH. MYC immunostaining negatively correlated with Gleason score (A), and pT-stage (D) in tumour samples. Negative BARK1 immunostaining characterised a subgroup of patients with high Gleason scores (B). Protein phosphatase1α immunostaining positively correlated with Gleason score (C) (Gs8–9 vs 5–7: P=0.001). P-values are derived from χ2test or Fisher's exact test.
